NCT05580107View on ClinicalTrials.gov

MDPK67b in Patients With Prostate Cancer

PHASE1RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 9, 2021

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
Prostate Cancer
Interventions
DRUG

MDPK67b

24 mg or 48 mg

Trial Locations (1)

8091

RECRUITING

Klinik für Urologie, UniversitätSpital Zürich (USZ), Zurich

Sponsors

Lead Sponsor

Med Discovery SA
All Listed Sponsors
collaborator

Camara and Partners Sàrl

UNKNOWN

collaborator

Soladis

INDUSTRY

lead

Med Discovery SA

INDUSTRY

NCT05580107 - MDPK67b in Patients With Prostate Cancer | Biotech Hunter | Biotech Hunter